Literature DB >> 28012233

Angiomatoid fibrous histiocytoma: A case of local recurrence and metastases to loco-regional lymph nodes that responded to chemotherapy.

Sally Ogden1, Srikrishna Harave1, Jo McPartland1, Bernadette Brennan2, Lee Jeys3, Paul Losty1, Barry Pizer1.   

Abstract

Angiomatoid fibrous histiocytoma (AFH) is a rare soft tissue tumour with intermediate malignant potential. We report the case of a patient with local recurrence of AFH in two locations and lymph node metastases 18 months after primary surgical excision. The patient was treated with six cycles of ifosfamide and doxorubicin chemotherapy and a further three courses of ifosfamide monotherapy. Reassessment imaging showed a good response to chemotherapy with reduction in size of the two tumours of local recurrence and the lymph node metastases. This case demonstrates that AFH can respond to chemotherapy, even though it is rarely used.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  angiomatoid; chemotherapy; fibrous; histiocytoma; treatment

Mesh:

Substances:

Year:  2016        PMID: 28012233     DOI: 10.1002/pbc.26376

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  3 in total

1.  Intracranial non-myxoid angiomatoid fibrous histiocytoma with EWSR1-CREB1 transcript fusion treated with doxorubicin: A case report.

Authors:  Louis Garnier; Tanguy Fenouil; Daniel Pissaloux; Roxana Ameli; François Ducray; David Meyronet; Jerome Honnorat
Journal:  Mol Clin Oncol       Date:  2021-05-09

2.  PD-L1 expression in angiomatoid fibrous histiocytoma.

Authors:  Joshua Byers; Hong Yin; Heather Rytting; Suzanna Logan; Mai He; Zhongxin Yu; Dehua Wang; Mikako Warren; Shamlal Mangray; Louis P Dehner; Shengmei Zhou
Journal:  Sci Rep       Date:  2021-01-26       Impact factor: 4.379

3.  Tocilizumab Controls Paraneoplastic Inflammatory Syndrome but Does Not Suppress Tumor Growth of Angiomatoid Fibrous Histiocytoma.

Authors:  Hideaki Sabe; Akitomo Inoue; Shigenori Nagata; Yoshinori Imura; Toru Wakamatsu; Satoshi Takenaka; Hironari Tamiya
Journal:  Case Rep Oncol Med       Date:  2021-06-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.